サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1761175

DNAプラスミド製造市場規模 2021年～2031年、世界と地域のシェア、動向、成長機会分析レポート：製品タイプ別、用途別、エンドユーザー別、地域別

DNA Plasmid Manufacturing Market Size and Forecast 2021 - 2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type, Application, End User and Geography

出版日
ページ情報
英文 222 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.89円
DNAプラスミド製造市場規模 2021年～2031年、世界と地域のシェア、動向、成長機会分析レポート：製品タイプ別、用途別、エンドユーザー別、地域別
出版日: 2025年06月19日
発行: The Insight Partners
ページ情報: 英文 222 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

DNAプラスミド製造市場は、2024年の6億8,638万米ドルから2031年には26億4,836万米ドルに達すると予測され、2025-2031年のCAGRは21.4%と推定されます。市場成長を促進する主な要因としては、遺伝子治療用プラスミド開発の増加、DNAプラスミドワクチン開発研究の拡大などが挙げられます。しかし、製造コストが高いことが市場の阻害要因となっています。

遺伝性疾患、希少疾患、その他のがんの有病率の増加は、遺伝子治療技術の進歩を加速させており、これらの技術は基本要素としてプラスミドDNAに大きく依存しています。プラスミドDNAは患者の細胞に遺伝物質を導入するのに役立ちます。プラスミドDNAは非ウイルス性ベクターとして機能し、欠陥遺伝子を修復したり置き換えたりする治療用遺伝子を送達します。ウイルス性ベクターとは異なり、プラスミドはより安全で、製造が容易で、安価であるため、遺伝子治療において普及しています。

遺伝子治療が前臨床開発から臨床試験、商業的発売へと移行するにつれて、高純度、GMPグレードのプラスミドDNAの大量需要が著しく高まっています。2023年3月、チャールス・リバー・ラボラトリーズ・インターナショナル社は、アデノ随伴ウイルス（AAV）ベースの遺伝子治療プログラムの早期発見から商業生産までの供給確保と合理化を目的とした、既製のpHelper（ヘルパープラスミド）の提供を開始することを発表しました。

遺伝子治療パイプラインの品質と規制上の要求を満たすための企業間のパートナーシップの拡大。2022年、マーテルとフォージ・バイオロジックスはウイルスベクターとプラスミドDNAのcGMP製造パートナーシップを発表しました。フォージ社は、マーテル社のプログラムであるMyr-201（単発性難聴のための新規遺伝子治療）のために、研究グレードおよびGMPパスウェイのプラスミド製造サービス、cGMPアデノ随伴ウイルス（AAV）プロセス開発およびスケールアップ製造サービスを提供します。

政府や規制当局も、遺伝子治療製品の迅速な承認や国のバイオテクノロジー・インフラ投資によって、この傾向を後押ししています。VGXI社は最近、テキサス州コンローにあるGMP施設のFDA査察に合格しました。この査察により、クライアントの生物製剤承認申請（BLA）が承認されました。VGXI社の業績は、プラスミドDNA製造のリーダーとしての信頼性を強化するとともに、商業段階の遺伝子治療、DNAワクチン、RNAベースの医薬品を可能にする上での重要性を強調するものです。

DNAプラスミド市場は、特殊な研究用サプライチェーンから、現代の治療開発に不可欠なバックボーンへと変貌しつつあります。そのため、遺伝子治療用プラスミドの開発増加がDNAプラスミド製造市場を牽引しています。

競合企業比較分析では、製品ポートフォリオ（製品満足度、製品特徴、入手可能性）、最近の市場動向（合併・買収、新製品発売・強化、投資・資金調達、受賞、合意、提携・協力、認知、拡大）、競合情勢のより良い意思決定と理解を助ける地域的存在に基づいて、DNAプラスミド製造市場を評価・分類しています。本レポートでは、世界のDNAプラスミド製造市場における主要ベンダーの最近の重要な動向と革新について深く調査しています。主な市場参入企業は、WuXi Biologics Inc、Charles River Laboratories International Inc、Catalent Inc、Thermo Fisher Scientific Inc、AGC Biologics AS、Takara Bio Inc、SK pharmteco Inc、Sartorius、Creative Biogene、GenScript Biotech Corporationなどです。

DNAプラスミド製造市場は、製品タイプによってGMPグレードとR&Dグレードに分けられます。GMPグレードセグメントは2024年にDNAプラスミド製造市場で最大のシェアを占め、2024～2031年の間に最も高いCAGRを記録すると予想されます。用途別では、DNAプラスミド製造市場は細胞・遺伝子治療、DNAワクチン、免疫療法、その他に区分されます。2024年には、細胞および遺伝子治療分野が市場の最大シェアを占めました。エンドユーザー別では、DNAプラスミド製造市場は製薬・バイオテクノロジー企業、CRO・CDMO、その他に区分されます。2024年には、製薬・バイオテクノロジー企業セグメントが最大シェアを占めています。

DNAプラスミド製造市場で事業を展開する企業は、様々な有機的・無機的戦略を採用しています。有機的戦略には主に、製品上市と製品承認が含まれます。無機的な成長戦略としては、買収、提携、パートナーシップなどが挙げられます。これらの成長戦略により、市場企業は事業を拡大し、地理的プレゼンスを高めるとともに、市場全体の成長に貢献することができます。さらに、買収や提携などの戦略は、顧客基盤を強化し、製品ポートフォリオを拡大するのに役立っています。DNAプラスミド製造市場の主要企業による重要な発展のいくつかを以下に示します。

2025年3月、WuXi Biologics社は組換えタンパク質とプラスミドDNA生産を促進するEffiX微生物発現プラットフォームを発表しました。EffiXは、高収率で安定した非ライソジェニック大腸菌発現システムに対する業界の需要に応えるように設計されています。EffiXは、非モノクローナル抗体（非Ab）組換えタンパク質およびプラスミドDNAを開発・製造するための包括的なソリューションとして、世界中のお客様にご利用いただいています。EffiXは、非Ab組換えタンパク質で15g/L以上、プラスミドDNAで1g/L以上の力価を達成し、複数の様式で高収率生産を実現します。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • アナリスト市場の展望

第3章 調査手法

  • 2次調査
  • 1次調査
    • 仮説の策定
    • マクロ経済要因分析
    • ファンデーション数値の開発
    • データの三角測量
    • 国レベルのデータ
  • 仮定と限界

第4章 DNAプラスミド製造市場の情勢

  • PEST分析

第5章 DNAプラスミド製造市場：主要市場力学

  • DNAプラスミド製造市場：主要市場力学
  • 市場促進要因
    • 遺伝子治療用プラスミド開発の増加
    • DNAプラスミドワクチン開発研究の拡大
  • 市場抑制要因
    • 高い製造コスト
  • 市場機会
    • 開発製造受託機関（CDMO）の拡大
  • 今後の動向
    • プラスミドDNA製造におけるデジタル技術の統合
  • 促進要因と抑制要因の影響

第6章 DNAプラスミド製造市場：世界市場分析

  • DNAプラスミド製造市場の収益、2021-2031年
  • DNAプラスミド製造市場の予測分析

第7章 DNAプラスミド製造市場の分析-製品タイプ別

  • GMPグレード
  • R&Dグレード

第8章 DNAプラスミド製造市場の分析-用途別

  • 細胞治療と遺伝子治療
  • DNAワクチン
  • 免疫療法
  • その他

第9章 DNAプラスミド製造市場の分析-エンドユーザー別

  • 製薬・バイオテクノロジー企業
  • CROおよびCDMO
  • その他

第10章 DNAプラスミド製造市場：地域別分析

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • オーストラリア
    • 韓国
    • アジア太平洋地域のその他諸国
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • アラブ首長国連邦
    • その他中東とアフリカ
  • 中南米
    • ブラジル
    • アルゼンチン
    • その他中南米

第11章 競合情勢

  • 主要企業別ヒートマップ分析
  • 企業シェア分析、2024年

第12章 業界情勢

  • ナイジェリア感染症体外診断薬市場における成長戦略
  • 有機的成長戦略
  • 無機的成長戦略

第13章 企業プロファイル

  • Sartorius AG
  • WuXi Biologics Inc
  • Charles River Laboratories International Inc
  • Catalent Inc
  • Thermo Fisher Scientific Inc.
  • AGC Biologics AS
  • Takara Bio Inc
  • Creative Biogene
  • SK Pharmteco Inc
  • GenScript Biotech Corporation

第14章 付録

図表

List Of Tables

  • Table 1. DNA Plasmid Manufacturing Market Segmentation
  • Table 2. DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million)
  • Table 3. DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million)
  • Table 4. DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 5. DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 6. DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 7. DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 8. DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 9. DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 10. North America: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 11. North America: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 12. North America: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 13. North America: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 14. North America: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 15. North America: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 16. North America: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Country
  • Table 17. North America: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
  • Table 18. United States: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 19. United States: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 20. United States: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 21. United States: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 22. United States: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 23. United States: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 24. Canada: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 25. Canada: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 26. Canada: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 27. Canada: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 28. Canada: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 29. Canada: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 30. Mexico: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 31. Mexico: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 32. Mexico: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 33. Mexico: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 34. Mexico: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 35. Mexico: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 36. Europe: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 37. Europe: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 38. Europe: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 39. Europe: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 40. Europe: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 41. Europe: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 42. Europe: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Country
  • Table 43. Europe: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
  • Table 44. Germany: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 45. Germany: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 46. Germany: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 47. Germany: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 48. Germany: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 49. Germany: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 50. United Kingdom: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 51. United Kingdom: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 52. United Kingdom: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 53. United Kingdom: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 54. United Kingdom: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 55. United Kingdom: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 56. France: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 57. France: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 58. France: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 59. France: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 60. France: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 61. France: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 62. Italy: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 63. Italy: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 64. Italy: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 65. Italy: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 66. Italy: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 67. Italy: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 68. Spain: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 69. Spain: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 70. Spain: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 71. Spain: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 72. Spain: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 73. Spain: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 74. Rest of Europe: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 75. Rest of Europe: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 76. Rest of Europe: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 77. Rest of Europe: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 78. Rest of Europe: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 79. Rest of Europe: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 80. Asia Pacific: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 81. Asia Pacific: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 82. Asia Pacific: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 83. Asia Pacific: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 84. Asia Pacific: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 85. Asia Pacific: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 86. Asia Pacific: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Country
  • Table 87. Asia Pacific: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
  • Table 88. China: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 89. China: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 90. China: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 91. China: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 92. China: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 93. China: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 94. Japan: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 95. Japan: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 96. Japan: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 97. Japan: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 98. Japan: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 99. Japan: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 100. India: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 101. India: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 102. India: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 103. India: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 104. India: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 105. India: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 106. Australia: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 107. Australia: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 108. Australia: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 109. Australia: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 110. Australia: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 111. Australia: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 112. South Korea: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 113. South Korea: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 114. South Korea: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 115. South Korea: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 116. South Korea: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 117. South Korea: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 118. Rest of APAC: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 119. Rest of APAC: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 120. Rest of APAC: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 121. Rest of APAC: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 122. Rest of APAC: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 123. Rest of APAC: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 124. Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 125. Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 126. Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 127. Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 128. Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 129. Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 130. Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Country
  • Table 131. Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
  • Table 132. Saudi Arabia: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 133. Saudi Arabia: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 134. Saudi Arabia: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 135. Saudi Arabia: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 136. Saudi Arabia: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 137. Saudi Arabia: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 138. South Africa: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 139. South Africa: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 140. South Africa: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 141. South Africa: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 142. South Africa: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 143. South Africa: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 144. United Arab Emirates: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 145. United Arab Emirates: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 146. United Arab Emirates: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 147. United Arab Emirates: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 148. United Arab Emirates: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 149. United Arab Emirates: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 150. Rest of Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 151. Rest of Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 152. Rest of Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 153. Rest of Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 154. Rest of Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 155. Rest of Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 156. South and Central America: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 157. South and Central America: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 158. South and Central America: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 159. South and Central America: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 160. South and Central America: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 161. South and Central America: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 162. South and Central America: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Country
  • Table 163. South and Central America: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
  • Table 164. Brazil: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 165. Brazil: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 166. Brazil: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 167. Brazil: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 168. Brazil: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 169. Brazil: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 170. Argentina: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 171. Argentina: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 172. Argentina: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 173. Argentina: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 174. Argentina: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 175. Argentina: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 176. Rest of South and Central America: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 177. Rest of South and Central America: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 178. Rest of South and Central America: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 179. Rest of South and Central America: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 180. Rest of South and Central America: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 181. Rest of South and Central America: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 182. Heat Map Analysis by Key Players
  • Table 183. Recent Organic Growth Strategies in the Nigeria Infectious Disease In-Vitro Diagnostics Market
  • Table 184. Recent Inorganic Growth Strategies in the Nigeria Infectious Disease In-Vitro Diagnostics Market
  • Table 185. Glossary of Terms, Infectious Disease Diagnostics Market

List Of Figures

  • Figure 1. DNA Plasmid Manufacturing Market Segmentation, by Geography
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. DNA Plasmid Manufacturing Market Revenue (US$ Million), 2021-2031
  • Figure 5. DNA Plasmid Manufacturing Market Share (%) - by Product Type (2024 and 2031)
  • Figure 6. GMP Grade: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. R&D grade: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. DNA Plasmid Manufacturing Market Share (%) - by Application (2024 and 2031)
  • Figure 9. Cell and Gene Therapy: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 10. DNA Vaccines: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Immunotherapy: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Others: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. DNA Plasmid Manufacturing Market Share (%) - by End User (2024 and 2031)
  • Figure 14. Pharmaceutical and Biotechnology Companies: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. CROs and CDMOs: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Others: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 17. DNA Plasmid Manufacturing Market Breakdown by Region, 2024 and 2031 (%)
  • Figure 18. North America: DNA Plasmid Manufacturing Market - Revenue, 2021-2031 (US$ Million)
  • Figure 19. North America: DNA Plasmid Manufacturing Market Breakdown, by Product Type (2024 and 2031)
  • Figure 20. North America: DNA Plasmid Manufacturing Market Breakdown, by Application (2024 and 2031)
  • Figure 21. North America: DNA Plasmid Manufacturing Market Breakdown, by End User (2024 and 2031)
  • Figure 22. North America: DNA Plasmid Manufacturing Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 23. United States: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 24. Canada: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 25. Mexico: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 26. Europe: DNA Plasmid Manufacturing Market - Revenue, 2021-2031 (US$ Million)
  • Figure 27. Europe: DNA Plasmid Manufacturing Market Breakdown, by Product Type (2024 and 2031)
  • Figure 28. Europe: DNA Plasmid Manufacturing Market Breakdown, by Application (2024 and 2031)
  • Figure 29. Europe: DNA Plasmid Manufacturing Market Breakdown, by End User (2024 and 2031)
  • Figure 30. Europe: DNA Plasmid Manufacturing Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 31. Germany: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 32. United Kingdom: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 33. France: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 34. Italy: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 35. Spain: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 36. Rest of Europe: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 37. Asia Pacific: DNA Plasmid Manufacturing Market - Revenue, 2021-2031 (US$ Million)
  • Figure 38. Asia Pacific: DNA Plasmid Manufacturing Market Breakdown, by Product Type (2024 and 2031)
  • Figure 39. Asia Pacific: DNA Plasmid Manufacturing Market Breakdown, by Application (2024 and 2031)
  • Figure 40. Asia Pacific: DNA Plasmid Manufacturing Market Breakdown, by End User (2024 and 2031)
  • Figure 41. Asia Pacific: DNA Plasmid Manufacturing Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 42. China: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 43. Japan: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 44. India: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 45. Australia: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 46. South Korea: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 47. Rest of APAC: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 48. Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue, 2021-2031 (US$ Million)
  • Figure 49. Middle East and Africa: DNA Plasmid Manufacturing Market Breakdown, by Product Type (2024 and 2031)
  • Figure 50. Middle East and Africa: DNA Plasmid Manufacturing Market Breakdown, by Application (2024 and 2031)
  • Figure 51. Middle East and Africa: DNA Plasmid Manufacturing Market Breakdown, by End User (2024 and 2031)
  • Figure 52. Middle East and Africa: DNA Plasmid Manufacturing Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 53. Saudi Arabia: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 54. South Africa: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 55. United Arab Emirates: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 56. Rest of Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 57. South and Central America: DNA Plasmid Manufacturing Market - Revenue, 2021-2031 (US$ Million)
  • Figure 58. South and Central America: DNA Plasmid Manufacturing Market Breakdown, by Product Type (2024 and 2031)
  • Figure 59. South and Central America: DNA Plasmid Manufacturing Market Breakdown, by Application (2024 and 2031)
  • Figure 60. South and Central America: DNA Plasmid Manufacturing Market Breakdown, by End User (2024 and 2031)
  • Figure 61. South and Central America: DNA Plasmid Manufacturing Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 62. Brazil: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 63. Argentina: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 64. Rest of South and Central America: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 65. Company Market Share Analysis, 2024
  • Figure 66. Growth Strategies in the Nigeria Infectious Disease In-Vitro Diagnostics Market
目次
Product Code: TIPRE00021640

The DNA plasmid Manufacturing Market is expected to reach US$ 2,648.36 Mn by 2031 from US$ 686.38 Mn in 2024; the market is estimated to grow at a CAGR of 21.4% during 2025-2031. Major factors driving the market growth include increasing plasmid developments for gene therapy and growing research on DNA plasmid vaccine development. However, high manufacturing costs among the market deterrents.

The rise in the prevalence of genetic diseases, orphan diseases, and other cancers has accelerated the advancement of gene therapy technologies, which are based largely on plasmid DNA as the fundamental element. Plasmid DNA helps introduce genetic material into patients' cells. It acts as a non-viral vector to deliver therapeutic genes that can fix or replace faulty genes. Unlike viral vectors, plasmids are safer, easier to produce, and cheaper, making them popular in gene therapy.

As gene therapies transition from preclinical development to clinical trials and commercial launch, the demand for substantial quantities of high-purity, GMP-grade plasmid DNA has escalated significantly. In March 2023, Charles River Laboratories International, Inc. announced the launch of its off-the-shelf pHelper (Helper Plasmid) offering, which is designed to secure supply and streamline adeno-associated virus (AAV)-based gene therapy programs from early discovery through commercial manufacturing.

Growing partnerships between companies to meet the quality and regulatory demands of gene therapy pipelines. In 2022, Myrtelle and Forge Biologics announced a viral vector and plasmid DNA cGMP manufacturing partnership. Forge will provide research-grade and GMP-Pathway plasmid manufacturing services as well as cGMP adeno-associated viral (AAV) process development and scale-up manufacturing services for Myrtelle's program, Myr-201 (novel gene therapy for monogenic hearing loss).

Governments and regulatory agencies are also helping to drive this trend with expedited approvals for gene therapy products and national biotech infrastructure investment. VGXI, Inc. recently completed a successful FDA inspection at its GMP facility in Conroe, Texas. This inspection led to the approval of a client's Biologics License Application (BLA). VGXI's achievement reinforces its credibility as a plasmid DNA manufacturing leader as well as underscores its importance in enabling commercial-stage gene therapies, DNA vaccines, and RNA-based medicines.

The DNA plasmid market is transforming from a specialized research supply chain to an essential backbone of contemporary therapeutic development. Therefore, the increasing development of plasmid for gene therapy drives the DNA plasmid manufacturing market.

The comparative company analysis evaluates and categorizes the DNA plasmid Manufacturing Market based on product portfolio (product satisfaction, product features, and availability), recent market developments (merger & acquisition, new product launch & enhancement, investment & funding, award, agreement, collaboration, & partnership, recognition, and expansion), and geographic presence that aids better decision-making and understanding of the competitive landscape. The report profoundly explores the recent significant developments and innovations by the leading vendors in the global DNA plasmid Manufacturing Market. The key market players are WuXi Biologics Inc, Charles River Laboratories International Inc, Catalent Inc, Thermo Fisher Scientific Inc., AGC Biologics AS, Takara Bio Inc, SK pharmteco Inc, Sartorius, Creative Biogene, GenScript Biotech Corporation

The DNA plasmid Manufacturing Market, based on product type, is divided into GMP Grade and R&D grade. The GMP Grade segment held the largest share of the DNA plasmid Manufacturing Market in 2024, and it is expected to register the highest CAGR during 2024-2031. Based on Application, the DNA plasmid Manufacturing Market is segmented into Cell and Gene Therapy, DNA Vaccines, Immunotherapy, and Others. In 2024, the cell and gene therapy segment held the largest share of the market. Based on end user, the DNA plasmid Manufacturing Market is segmented into Pharmaceutical and Biotechnology Companies, CROs and CDMOs and Others. In 2024, the Pharmaceutical and Biotechnology Companies segment held the largest share of the market.

Various organic and inorganic strategies are adopted by companies operating in the DNA plasmid Manufacturing Market. The organic strategies mainly include product launches and product approvals. Inorganic growth strategies witnessed in the market are acquisitions, collaboration, and partnerships. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, along with contributing to the overall market growth. Furthermore, strategies such as acquisitions and partnerships helped strengthen their customer base and extend their product portfolios. A few of the significant developments by key players in the DNA plasmid Manufacturing Market are listed below.

In March 2025, WuXi Biologics Launched EffiX Microbial Expression Platform to Boost Recombinant Protein and Plasmid DNA Production. EffiX is designed to meet the industry's demand for a high-yield, stable, and non-lysogenic E. coli expression system. It serves as a comprehensive solution for developing and manufacturing non-monoclonal antibody (non-mAb) recombinant proteins and plasmid DNA for clients across the globe. EffiX delivers high-yield production across multiple modalities, achieving titers of over 15 g/L for non-mAb recombinant proteins and over 1 g/L for plasmid DNA.

Table Of Contents

1. Introduction

  • 1.1 Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Analyst Market Outlook

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:
  • 3.3 Assumptions and Limitations

4. DNA Plasmid Manufacturing Market Landscape

  • 4.1 PEST Analysis

5. DNA Plasmid Manufacturing Market - Key Market Dynamics

  • 5.1 DNA Plasmid Manufacturing Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Increasing Plasmid Developments for Gene Therapy
    • 5.2.2 Growing Research on DNA Plasmid Vaccine Development
  • 5.3 Market Restraints
    • 5.3.1 High Manufacturing Costs
  • 5.4 Market Opportunities
    • 5.4.1 Expansion of Contract Development and Manufacturing Organizations (CDMOs)
  • 5.5 Future Trends
    • 5.5.1 Integration of Digital Technologies in Plasmid DNA Manufacturing
  • 5.6 Impact of Drivers and Restraints:

6. DNA Plasmid Manufacturing Market - Global Market Analysis

  • 6.1 DNA Plasmid Manufacturing Market Revenue (US$ Million), 2021-2031
  • 6.2 DNA Plasmid Manufacturing Market Forecast Analysis

7. DNA Plasmid Manufacturing Market Analysis - by Product Type

  • 7.1 GMP Grade
    • 7.1.1 Overview
    • 7.1.2 GMP Grade: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 R&D grade
    • 7.2.1 Overview
    • 7.2.2 R&D grade: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)

8. DNA Plasmid Manufacturing Market Analysis - by Application

  • 8.1 Cell and Gene Therapy
    • 8.1.1 Overview
    • 8.1.2 Cell and Gene Therapy: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 DNA Vaccines
    • 8.2.1 Overview
    • 8.2.2 DNA Vaccines: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Immunotherapy
    • 8.3.1 Overview
    • 8.3.2 Immunotherapy: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.4 Others
    • 8.4.1 Overview
    • 8.4.2 Others: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)

9. DNA Plasmid Manufacturing Market Analysis - by End User

  • 9.1 Pharmaceutical and Biotechnology Companies
    • 9.1.1 Overview
    • 9.1.2 Pharmaceutical and Biotechnology Companies: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.2 CROs and CDMOs
    • 9.2.1 Overview
    • 9.2.2 CROs and CDMOs: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.3 Others
    • 9.3.1 Overview
    • 9.3.2 Others: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)

10. DNA Plasmid Manufacturing Market - Geographical Analysis

  • 10.1 Overview
  • 10.2 North America
    • 10.2.1 North America DNA Plasmid Manufacturing Market Overview
    • 10.2.2 North America: DNA Plasmid Manufacturing Market - Revenue, 2021-2031 (US$ Million)
    • 10.2.3 North America: DNA Plasmid Manufacturing Market Breakdown, by Product Type
      • 10.2.3.1 North America: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Product Type
    • 10.2.4 North America: DNA Plasmid Manufacturing Market Breakdown, by Application
      • 10.2.4.1 North America: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Application
    • 10.2.5 North America: DNA Plasmid Manufacturing Market Breakdown, by End User
      • 10.2.5.1 North America: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by End User
    • 10.2.6 North America: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Country
      • 10.2.6.1 North America: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Country
      • 10.2.6.2 United States: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.2.6.2.1 United States: DNA Plasmid Manufacturing Market Breakdown, by Product Type
        • 10.2.6.2.2 United States: DNA Plasmid Manufacturing Market Breakdown, by Application
        • 10.2.6.2.3 United States: DNA Plasmid Manufacturing Market Breakdown, by End User
      • 10.2.6.3 Canada: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.2.6.3.1 Canada: DNA Plasmid Manufacturing Market Breakdown, by Product Type
        • 10.2.6.3.2 Canada: DNA Plasmid Manufacturing Market Breakdown, by Application
        • 10.2.6.3.3 Canada: DNA Plasmid Manufacturing Market Breakdown, by End User
      • 10.2.6.4 Mexico: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.2.6.4.1 Mexico: DNA Plasmid Manufacturing Market Breakdown, by Product Type
        • 10.2.6.4.2 Mexico: DNA Plasmid Manufacturing Market Breakdown, by Application
        • 10.2.6.4.3 Mexico: DNA Plasmid Manufacturing Market Breakdown, by End User
  • 10.3 Europe
    • 10.3.1 Europe DNA Plasmid Manufacturing Market Overview
    • 10.3.2 Europe: DNA Plasmid Manufacturing Market - Revenue, 2021-2031 (US$ Million)
    • 10.3.3 Europe: DNA Plasmid Manufacturing Market Breakdown, by Product Type
      • 10.3.3.1 Europe: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Product Type
    • 10.3.4 Europe: DNA Plasmid Manufacturing Market Breakdown, by Application
      • 10.3.4.1 Europe: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Application
    • 10.3.5 Europe: DNA Plasmid Manufacturing Market Breakdown, by End User
      • 10.3.5.1 Europe: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by End User
    • 10.3.6 Europe: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Country
      • 10.3.6.1 Europe: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Country
      • 10.3.6.2 Germany: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.3.6.2.1 Germany: DNA Plasmid Manufacturing Market Breakdown, by Product Type
        • 10.3.6.2.2 Germany: DNA Plasmid Manufacturing Market Breakdown, by Application
        • 10.3.6.2.3 Germany: DNA Plasmid Manufacturing Market Breakdown, by End User
      • 10.3.6.3 United Kingdom: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.3.6.3.1 United Kingdom: DNA Plasmid Manufacturing Market Breakdown, by Product Type
        • 10.3.6.3.2 United Kingdom: DNA Plasmid Manufacturing Market Breakdown, by Application
        • 10.3.6.3.3 United Kingdom: DNA Plasmid Manufacturing Market Breakdown, by End User
      • 10.3.6.4 France: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.3.6.4.1 France: DNA Plasmid Manufacturing Market Breakdown, by Product Type
        • 10.3.6.4.2 France: DNA Plasmid Manufacturing Market Breakdown, by Application
        • 10.3.6.4.3 France: DNA Plasmid Manufacturing Market Breakdown, by End User
      • 10.3.6.5 Italy: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.3.6.5.1 Italy: DNA Plasmid Manufacturing Market Breakdown, by Product Type
        • 10.3.6.5.2 Italy: DNA Plasmid Manufacturing Market Breakdown, by Application
        • 10.3.6.5.3 Italy: DNA Plasmid Manufacturing Market Breakdown, by End User
      • 10.3.6.6 Spain: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.3.6.6.1 Spain: DNA Plasmid Manufacturing Market Breakdown, by Product Type
        • 10.3.6.6.2 Spain: DNA Plasmid Manufacturing Market Breakdown, by Application
        • 10.3.6.6.3 Spain: DNA Plasmid Manufacturing Market Breakdown, by End User
      • 10.3.6.7 Rest of Europe: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.3.6.7.1 Rest of Europe: DNA Plasmid Manufacturing Market Breakdown, by Product Type
        • 10.3.6.7.2 Rest of Europe: DNA Plasmid Manufacturing Market Breakdown, by Application
        • 10.3.6.7.3 Rest of Europe: DNA Plasmid Manufacturing Market Breakdown, by End User
  • 10.4 Asia Pacific
    • 10.4.1 Asia Pacific DNA Plasmid Manufacturing Market Overview
    • 10.4.2 Asia Pacific: DNA Plasmid Manufacturing Market - Revenue, 2021-2031 (US$ Million)
    • 10.4.3 Asia Pacific: DNA Plasmid Manufacturing Market Breakdown, by Product Type
      • 10.4.3.1 Asia Pacific: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Product Type
    • 10.4.4 Asia Pacific: DNA Plasmid Manufacturing Market Breakdown, by Application
      • 10.4.4.1 Asia Pacific: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Application
    • 10.4.5 Asia Pacific: DNA Plasmid Manufacturing Market Breakdown, by End User
      • 10.4.5.1 Asia Pacific: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by End User
    • 10.4.6 Asia Pacific: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Country
      • 10.4.6.1 Asia Pacific: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Country
      • 10.4.6.2 China: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.4.6.2.1 China: DNA Plasmid Manufacturing Market Breakdown, by Product Type
        • 10.4.6.2.2 China: DNA Plasmid Manufacturing Market Breakdown, by Application
        • 10.4.6.2.3 China: DNA Plasmid Manufacturing Market Breakdown, by End User
      • 10.4.6.3 Japan: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.4.6.3.1 Japan: DNA Plasmid Manufacturing Market Breakdown, by Product Type
        • 10.4.6.3.2 Japan: DNA Plasmid Manufacturing Market Breakdown, by Application
        • 10.4.6.3.3 Japan: DNA Plasmid Manufacturing Market Breakdown, by End User
      • 10.4.6.4 India: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.4.6.4.1 India: DNA Plasmid Manufacturing Market Breakdown, by Product Type
        • 10.4.6.4.2 India: DNA Plasmid Manufacturing Market Breakdown, by Application
        • 10.4.6.4.3 India: DNA Plasmid Manufacturing Market Breakdown, by End User
      • 10.4.6.5 Australia: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.4.6.5.1 Australia: DNA Plasmid Manufacturing Market Breakdown, by Product Type
        • 10.4.6.5.2 Australia: DNA Plasmid Manufacturing Market Breakdown, by Application
        • 10.4.6.5.3 Australia: DNA Plasmid Manufacturing Market Breakdown, by End User
      • 10.4.6.6 South Korea: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.4.6.6.1 South Korea: DNA Plasmid Manufacturing Market Breakdown, by Product Type
        • 10.4.6.6.2 South Korea: DNA Plasmid Manufacturing Market Breakdown, by Application
        • 10.4.6.6.3 South Korea: DNA Plasmid Manufacturing Market Breakdown, by End User
      • 10.4.6.7 Rest of APAC: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.4.6.7.1 Rest of APAC: DNA Plasmid Manufacturing Market Breakdown, by Product Type
        • 10.4.6.7.2 Rest of APAC: DNA Plasmid Manufacturing Market Breakdown, by Application
        • 10.4.6.7.3 Rest of APAC: DNA Plasmid Manufacturing Market Breakdown, by End User
  • 10.5 Middle East and Africa
    • 10.5.1 Middle East and Africa DNA Plasmid Manufacturing Market Overview
    • 10.5.2 Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue, 2021-2031 (US$ Million)
    • 10.5.3 Middle East and Africa: DNA Plasmid Manufacturing Market Breakdown, by Product Type
      • 10.5.3.1 Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Product Type
    • 10.5.4 Middle East and Africa: DNA Plasmid Manufacturing Market Breakdown, by Application
      • 10.5.4.1 Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Application
    • 10.5.5 Middle East and Africa: DNA Plasmid Manufacturing Market Breakdown, by End User
      • 10.5.5.1 Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by End User
    • 10.5.6 Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Country
      • 10.5.6.1 Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Country
      • 10.5.6.2 Saudi Arabia: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.5.6.2.1 Saudi Arabia: DNA Plasmid Manufacturing Market Breakdown, by Product Type
        • 10.5.6.2.2 Saudi Arabia: DNA Plasmid Manufacturing Market Breakdown, by Application
        • 10.5.6.2.3 Saudi Arabia: DNA Plasmid Manufacturing Market Breakdown, by End User
      • 10.5.6.3 South Africa: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.5.6.3.1 South Africa: DNA Plasmid Manufacturing Market Breakdown, by Product Type
        • 10.5.6.3.2 South Africa: DNA Plasmid Manufacturing Market Breakdown, by Application
        • 10.5.6.3.3 South Africa: DNA Plasmid Manufacturing Market Breakdown, by End User
      • 10.5.6.4 United Arab Emirates: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.5.6.4.1 United Arab Emirates: DNA Plasmid Manufacturing Market Breakdown, by Product Type
        • 10.5.6.4.2 United Arab Emirates: DNA Plasmid Manufacturing Market Breakdown, by Application
        • 10.5.6.4.3 United Arab Emirates: DNA Plasmid Manufacturing Market Breakdown, by End User
      • 10.5.6.5 Rest of Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.5.6.5.1 Rest of Middle East and Africa: DNA Plasmid Manufacturing Market Breakdown, by Product Type
        • 10.5.6.5.2 Rest of Middle East and Africa: DNA Plasmid Manufacturing Market Breakdown, by Application
        • 10.5.6.5.3 Rest of Middle East and Africa: DNA Plasmid Manufacturing Market Breakdown, by End User
  • 10.6 South and Central America
    • 10.6.1 South and Central America DNA Plasmid Manufacturing Market Overview
    • 10.6.2 South and Central America: DNA Plasmid Manufacturing Market - Revenue, 2021-2031 (US$ Million)
    • 10.6.3 South and Central America: DNA Plasmid Manufacturing Market Breakdown, by Product Type
      • 10.6.3.1 South and Central America: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Product Type
    • 10.6.4 South and Central America: DNA Plasmid Manufacturing Market Breakdown, by Application
      • 10.6.4.1 South and Central America: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Application
    • 10.6.5 South and Central America: DNA Plasmid Manufacturing Market Breakdown, by End User
      • 10.6.5.1 South and Central America: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by End User
    • 10.6.6 South and Central America: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Country
      • 10.6.6.1 South and Central America: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Country
      • 10.6.6.2 Brazil: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.6.6.2.1 Brazil: DNA Plasmid Manufacturing Market Breakdown, by Product Type
        • 10.6.6.2.2 Brazil: DNA Plasmid Manufacturing Market Breakdown, by Application
        • 10.6.6.2.3 Brazil: DNA Plasmid Manufacturing Market Breakdown, by End User
      • 10.6.6.3 Argentina: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.6.6.3.1 Argentina: DNA Plasmid Manufacturing Market Breakdown, by Product Type
        • 10.6.6.3.2 Argentina: DNA Plasmid Manufacturing Market Breakdown, by Application
        • 10.6.6.3.3 Argentina: DNA Plasmid Manufacturing Market Breakdown, by End User
      • 10.6.6.4 Rest of South and Central America: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.6.6.4.1 Rest of South and Central America: DNA Plasmid Manufacturing Market Breakdown, by Product Type
        • 10.6.6.4.2 Rest of South and Central America: DNA Plasmid Manufacturing Market Breakdown, by Application
        • 10.6.6.4.3 Rest of South and Central America: DNA Plasmid Manufacturing Market Breakdown, by End User

11. Competitive Landscape

  • 11.1 Heat Map Analysis by Key Players
  • 11.2 Company Market Share Analysis, 2024

12. Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in the Nigeria Infectious Disease In-Vitro Diagnostics Market
  • 12.3 Organic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Inorganic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Sartorius AG
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 WuXi Biologics Inc
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Charles River Laboratories International Inc
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Catalent Inc
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Thermo Fisher Scientific Inc.
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 AGC Biologics AS
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Takara Bio Inc
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
  • 13.8 Creative Biogene
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 SK Pharmteco Inc
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 GenScript Biotech Corporation
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms